Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Non-comparative Study to Evaluate Cognitive Functioning in Remitted Depression Outpatients During Long-term Preventive Treatment With Fluvoxamine

NCT02016261 is registered in ClinicalTrials.gov with Moscow Research Institute of Psychiatry as lead sponsor.

NCT NCT02016261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Non-comparative Study to Evaluate Cognitive Functioning in Remitted Depression Outpatients During Long-term Preventive Treatment With Fluvoxamine
Lead sponsor
Moscow Research Institute of Psychiatry
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
July 31, 2015
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent depressive disorder